Stay informed with the latest litigation news. Explore now

IP Verse

Prolyl Hydroxylase Inhibitors And Methods Of Use - EP3357911B1

EP3357911

AKEBIA THERAPEUTICS
Application Number
EP18158907A
Filing Date
Jun 26, 2007
Status
Granted And Under Opposition
Apr 8, 2022
Grant Date
May 11, 2022
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3007695B1
EP3277270B1

Bibliography

The patent EP3357911B1 was granted to Akebia Therapeutics on May 11, 2022 following the initial filing on Jun 26, 2007 under the application number EP18158907A . The current legal status of the patent is Granted And Under Opposition.

Patent Summary

Patent Family New

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

FIBROGENFeb 13, 2023WITHDRAWN

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents